Who
Barbara Ryan
Director
Company insider
Files Form 4 as: Director, MiNK Therapeutics; Director, Indivior Pharmaceuticals; Director, Azitra; Director, INVO Fertility.
In numbers
- Trades disclosed
- 62
- Buys
- 4
- Sells
- 5
- Bought
- $67K
- Sold
- $93K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 27 Nov 2020
- Last trade
- 1 Sep 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K1,622 at $10.95 | filing |
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K1,622 at $10.95 | filing |
| 4 Jun 2026filed 5 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,342500 at $12.68 | filing |
| 4 Jun 2026filed 5 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $13K1,000 at $12.80 | filing |
| 4 Jun 2026filed 5 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,340500 at $12.68 | filing |
| 4 Jun 2026filed 5 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $13K1,000 at $12.80 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K1,434 at $12.38 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K1,434 at $12.38 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 13 Mar 2026filed 13 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $2498 at $31.09 | filing |
| 13 Mar 2026filed 13 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $2498 at $31.09 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,585300 at $15.28 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,783500 at $15.57 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,650500 at $15.30 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,584300 at $15.28 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,785500 at $15.57 | filing |
| 10 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,650500 at $15.30 | filing |
| 9 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,035200 at $10.17 | filing |
| 9 Mar 2026filed 11 Mar 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,034200 at $10.17 | filing |
News
No headline names them, or the companies they trade most, lately.